Clinical Trials Logo

Erectile Dysfunction clinical trials

View clinical trials related to Erectile Dysfunction.

Filter by:

NCT ID: NCT04172558 Recruiting - Clinical trials for Erectile Dysfunction

Intracavernous Injection of Botox 100 U for Treatment of PDE5Is Inconvenient Patients With ED

Start date: March 10, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

There is a new emerging concept that Botulinum Toxin Type A may have a potential role in treatment of erectile dysfunction with a longer duration of action. So, the investigators opted to perform this study to compare ICI of Botulinum Toxin Type A versus Trimix for treatment of ED.

NCT ID: NCT04170790 Not yet recruiting - Clinical trials for Diabetes Mellitus, Type 2

Evaluation of Drug Interactions of Saxagliptin With Sildenafil in Healthy Volunteers

Start date: December 1, 2019
Phase: N/A
Study type: Interventional

Patients with diabetes are three times more likely to develop erectile dysfunction (ED), and longer duration of diabetes is strongly associated with ED. The possibility of pharmacokinetic interactions may occur as the two drugs are metabolized by hepatic CYP3A4 and their co administration may affect their plasma concentrations. the aim of work is to investigate the effect of sildenafil a CYP3A4 substrate and inhibitor on the pharmacokinetics and safety of Saxagliptin, a CYP3A4 substrate Subjects and Methods: Eighteen healthy volunteers will be recruited in Sequential, single center study to determine pharmacokinetic parameters of Saxagliptin, and sildenafil,(AUC0→∞), (AUC0→t); Cmax; tmax; t½, k; ka) will be measured using validated LC-MS/MS method. Therapeutic doses will be given to volunteers as follows: Sildenafil 50 mg single dose on day 1, then washout period from day 2 till day 8. Saxagliptin 5 mg once/day will be given from day 9 till day 12, then on day 13 the two drugs will be co-administered. Blood samples (5ml) for pharmacokinetic analysis will be collected on days 1 and 13 for Sildenafil as well as on days 12 and 13 for Saxagliptin.

NCT ID: NCT04164355 Completed - Clinical trials for Erectile Dysfunction Following Radical Prostatectomy

Study of Retinal and Choriocapillary Vascular Changes in Patients Undergoing Tadalafil 20mg

Start date: July 4, 2020
Phase:
Study type: Observational

This study evaluates the retinal and choriocapillary vascular features in patients under the effects of Tadalafil 20mg using optical coherence tomography angiography.

NCT ID: NCT04136288 Completed - Clinical trials for Erectile Dysfunction

Low Intensity Shock Wave Therapy in the Management of Erectile Dysfunction

Start date: December 1, 2019
Phase: N/A
Study type: Interventional

Researchers are evaluating the efficacy of low intensity shockwave therapy (LISWT) via MoreNova in the treatment of erectile dysfunction (ED).

NCT ID: NCT04129814 Completed - Periodontitis Clinical Trials

The Effects of Non -Surgical Periodontal Treatment on The Severity of Erectile Dysfunction

Start date: April 2016
Phase: N/A
Study type: Interventional

The aim of the present study is to study the influence of periodontal therapy (non-surgical) on the severity of erectile dysfunction(ED) among patients with chronic periodontitis and moderate or severe ED.

NCT ID: NCT04126252 Completed - Clinical trials for Erectile Dysfunction

Pharmacotherapy and Psychotherapy in the Treatment of Erectile Dysfunction

Start date: August 29, 2018
Phase: N/A
Study type: Interventional

The study involved the administration of pharmacotherapy and cognitive behavior psychotherapy to individuals suffering from erectile dysfunction. The study was randomized controlled trial with four arms involving a control group.

NCT ID: NCT04116060 Recruiting - Clinical trials for Erectile Dysfunction

Dietary Nitrate and Erectile Dysfunction

Start date: February 17, 2020
Phase: N/A
Study type: Interventional

An expanding number of studies suggest a therapeutic role for nitrate and nitrite, most notably in treatment and prevention of cardiovascular disease including ischemia-reperfusion injury and hypertension. The nutritional aspects of these cardioprotective effects are particularly intriguing since nitrate is abundant in our everyday diet. Nitrate improves vascular functions in old adults and improves ischemia reperfusion injury in experimental models. Whether dietary nitrate improves erectile dysfunction is not known and will be investigated in the present study.

NCT ID: NCT04114240 Completed - Clinical trials for Erectile Dysfunction

French Study in Real Life Evaluating Xybilun

XY-FILM
Start date: May 23, 2018
Phase:
Study type: Observational

Collecting Xybilun (Viagra's generic) efficacity, tolerance, convenience and patients/doctors satisfaction's data at different doses (50-75-100 mg), is the aim of the study.

NCT ID: NCT04100759 Completed - Smoking Clinical Trials

A Comparative Pharmacokinetic and Pharmacodynamic Study of Sildenafil in Adult Smokers and Non Smokers

Start date: June 11, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

Smokers are at higher risk of developing Erectile dysfunction (ED) independent of age and comorbidities. Sildenafil is a cytochrome p3A4 (CYP3A4) substrate used for enhancing the erectile function in males. The study purpose is to determine the effect of smoking on male sexual function based on the international index of erectile function score (IIEF) and investigate the effect of smoking (Cigarettes or marijuana) on the pharmacokinetics and pharmacodynamics of sildenafil.

NCT ID: NCT04064671 Recruiting - Clinical trials for Erectile Dysfunction

ZEPHYR: A Study Evaluating Surgical Outcome After Implantation of the Zephyr ZSI 475 FTM Inflatable Penile Implant in the Neophallus After Female-to-male Sex Reassignment Surgery

Start date: September 19, 2017
Phase:
Study type: Observational

This study will look into the surgical outcome after implantation of the Zephyr ZSI 475 FTM in the neophallus.